Table 1 Characteristics of patients with ESKD secondary to MPGN or all other GN who commenced dialysis in Australia and New Zealand 1996-2016 (unmatched and propensity score matched patients)
Characteristic | Unmatched Cohort | Matched Cohort | ||
|---|---|---|---|---|
MPGN (n = 441) | All other GN (n = 12,029) | MPGN (n = 440) | All other GN (n = 440) | |
Age (years) | 51 (38–64) | 55 (41–67) | 53 (41–65) | 51 (38–64) |
Male | 271 (61%) | 7655 (64%) | 271 (62%) | 290 (66%) |
Race | ||||
Caucasian | 299 (68%) | 8948 (74%) | 299 (68%) | 299 (68%) |
ATSI | 40 (9%) | 602 (5%) | 40 (9%) | 52 (12%) |
MPI | 69 (16%) | 886 (7%) | 68 (15%) | 55 (12%) |
Asian | 24 (5%) | 1336 (11%) | 24 (5%) | 27 (6%) |
Other | 9 (2%) | 257 (2%) | 9 (2%) | 7 (2%) |
Dialysis Era | ||||
1996–2006 | 264 (60%) | 6275 (52%) | 263 (60%) | 267 (61%) |
2007–2016 | 177 (40%) | 5754 (48%) | 177 (40%) | 173 (39%) |
Hepatitis C Antibody Positive | 47 (11%) | 183 (2%) | 46 (10%) | 50 (11%) |
Current Smoker | 90 (20%) | 1642 (14%) | 90 (20%) | 96 (22%) |
Diabetes Mellitus | 75 (17%) | 1579 (13%) | 74 (17%) | 80 (18%) |
Chronic Lung Disease | 46 (10%) | 1362 (11%) | 46 (10%) | 49 (11%) |
Coronary Artery Disease | 76 (17%) | 2288 (19%) | 76 (17%) | 86 (20%) |
Peripheral Vascular Disease | 28 (6%) | 872 (7%) | 28 (6%) | 37 (8%) |
Cerebrovascular Disease | 26 (6%) | 812 (7%) | 26 (6%) | 33 (8%) |
Previous history of Cancer | 44 (10%) | 879 (7%) | 44 (10%) | 40 (9%) |
Late referral for KRT | 97 (22%) | 2798 (23%) | 96 (22%) | 102 (23%) |
First KRT Modality | ||||
HD | 329 (75%) | 8620 (72%) | 329 (75%) | 328 (75%) |
PD | 112 (25%) | 3409 (28%) | 111 (25%) | 112 (25%) |